BACKGROUND
Despite improvements in overall survival for pediatric cancers,
treatment disparities remain for racial/ethnic minorities compared to
non-Hispanic white; however, the impact of race on treatment outcomes
for pediatric brain and central nervous system (CNS) tumors in the
United States are not well known.